Actionnariat et activité des initiés pour Kezar Life Sciences, Inc. (KZR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $7.29 |
| Capitalisation | $54M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-05-11 | Wallace Courtney | D-Return | 3,500 | $92K |
| 2026-05-11 | Wallace Courtney | D-Return | 5,000 | $34K |
| 2026-05-11 | Wallace Courtney | D-Return | 5,000 | $22K |
| 2026-05-11 | Wallace Courtney | D-Return | 2,600 | $59K |
| 2026-05-11 | Schiller Mark C. | U-Tender | 2,739 | $19K |
| 2026-05-11 | Schiller Mark C. | D-Return | 25,000 | $233K |
| 2026-05-11 | Schiller Mark C. | D-Return | 24,500 | $161K |
| 2026-05-11 | Schiller Mark C. | D-Return | 12,000 | $76K |
| 2026-05-11 | Schiller Mark C. | D-Return | 16,499 | $376K |
| 2026-05-11 | Klearman Micki | D-Return | 3,500 | $92K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.7M | $51.0M | $24.2M | $15.0M | $21.2M | $62.9M | $40.5M | $35.5M | $41.7M | $71.9M |
| Placements à Court Terme | 0 | 0 | $83.2M | $63.3M | $119.2M | $145.5M | $236.1M | $165.9M | $90.5M | 0 |
| Créances | 0 | 0 | 0 | $642000 | $766000 | 0 | 0 | $2.3M | $424000 | $1.9M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $10.5M | $52.3M | $109.8M | $81.1M | $144.8M | $211.7M | $285.7M | $206.9M | $137.5M | $75.7M |
| Immobilisations Corporelles | $862000 | $1.5M | $4.6M | $8.1M | $6.7M | $6.0M | $13.2M | $8.7M | $4.8M | $915000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $11.4M | $54.2M | $114.7M | $89.5M | $151.8M | $217.9M | $299.6M | $221.2M | $144.7M | $76.6M |
| Dettes Fournisseurs | $466000 | $547000 | $193000 | $823000 | $2.4M | $2.0M | $2.5M | $8.3M | $3.7M | $507000 |
| Dette à Court Terme | 0 | 0 | 0 | $900000 | $1.0M | 0 | 0 | 0 | $5.2M | 0 |
| Passifs Courants | $651000 | $1.5M | $3.3M | $6.0M | $6.4M | $8.2M | $11.0M | $17.7M | $20.3M | $6.6M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | $9.6M | $9.8M | $10.1M | $5.1M | 0 |
| Passifs Totaux | $28.9M | $79.9M | $5.9M | $11.5M | $10.9M | $21.1M | $29.7M | $33.7M | $27.8M | $6.6M |
| Réserves | -$17.5M | -$26.0M | -$49.2M | -$84.3M | -$126.0M | -$180.7M | -$248.9M | -$350.8M | -$434.5M | -$490.5M |
| Capitaux Propres | -$17.4M | -$25.7M | $108.8M | $78.0M | $141.0M | $196.9M | $269.9M | $187.6M | $116.9M | $70.1M |
| Dette Totale | 0 | 0 | 0 | $6.4M | $5.5M | $14.0M | $21.3M | $18.9M | $16.2M | $2.3M |
| Dette Nette | -$9.7M | -$51.0M | -$107.4M | -$71.8M | -$135.0M | -$194.3M | -$255.3M | -$182.4M | -$116.1M | -$69.6M |
| Fonds de Roulement | $9.8M | $50.8M | $106.5M | $75.1M | $138.4M | $203.4M | $274.7M | $189.2M | $117.2M | $69.2M |
Santé financière
| Dette / Capitaux propres | 0.02 |
| Ratio de liquidité | 24.46 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -5.93 |
Rentabilité
| Rentabilité des capitaux propres | -79.96% |
| Rentabilité du capital investi | -72.20% |
| Rentabilité des actifs | -73.11% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: CCCC · CRNX · ERAS · EWTX · REPL · SRRK · STRO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de KZR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions